Indoco Remedies Limited

Indoco Remedies Limited

Performance

Today's Low Today's High
316.10 310.25
343.55 343.90
52 Week Low 52 Week High
286.60 (04-Jun-2024) 286.50 (04-Jun-2024)
415.00 (20-Jan-2024) 416.95 (01-Jan-2024)

Open
316.10 310.25
Previous Close
318.75 318.50
Volume
2.26
Total Traded value
7.52 (₹ Lakhs)
Upper circuit
382.50 451.85
Lower circuit
255.00 301.25

Market Depth

Buy Order Quantity Sell Order Quantity
4,207
0

Bid PriceQuantity
338.804,207.00
0.000.00
0.000.00
0.000.00
0.000.00
Total:4,207
Ask PriceQuantity
0.000.00
0.000.00
0.000.00
0.000.00
0.000.00
Total:--

Fundamentals

Market Cap: ₹31.54 Cr
PE Ratio (TTM): 34.42
PB Ratio: 2.57
Industry P/E:125.49
Debt to Equity:0.00
ROE:7.47
EPS (TTM):9.25
Book Value:0.00
Face Value: 2.00

Financials

Jun, 2023Jun, 2023Jun, 2023Jun, 2023Jun, 2023
Revenue24.39 Cr152.33 Cr1,230.87 Cr652.87 Cr422.88 Cr
Profit-2.36 Cr5.18 Cr18.95 Cr51.74 Cr25.94 Cr
Expense26.86 Cr145.86 Cr1,228.84 Cr590.64 Cr387.62 Cr
Comprehensive income-2.36 Cr4.64 Cr25.73 Cr51.46 Cr25.71 Cr
EPS-0.166.700.1314.592.81
Indoco Remedies Limited is a pharmaceutical company based in Mumbai, India. With a history dating back to 1945, the company specializes in manufacturing and selling formulations and active pharmaceutical ingredients both in India and internationally.

Indoco Remedies offers a wide range of products across various therapeutic categories. Their respiratory products, including Karvol Plus, Febrex Plus, and Tuspel, cater to respiratory health. For stomatological care, they provide Sensodent-K, Sensoform Toothpaste, Sensoform Gum Paint, Rexidin M, Rexidin SRS, RR Sensoform Dental, Snowdent, Kidodent, Rexidin Plus, and Dentogel. Gastrointestinal products like Carmicide, Cyclopam, Cyclomeff, and Nosic are also part of their portfolio.

The company also manufactures pain/analgesics products such as Lignox and T-lac, as well as ophthal/otologicals products like Renolen, Homide, Dexoren S, Zincoren, Otorex, Mofloren-D, and Mofloren LP. Additionally, they offer vitamins, minerals, and nutrients like Methycal, Cital UTI, SM Fibro, Cal Aid, SM Fibro, MCBM DHA, and Apispur.

Indoco Remedies caters to various medical specialties, including urology with products like Carmicide and Cital, dermatology with Cloben G and Scabex, anti-infectives with ATM, blood-related conditions with Hemsyl, gynecological care with MCBM 69 and D Chiro, and anti-haemorrhoidal care with Spear.

Apart from their product range, the company also provides analytical services such as impurity profile analysis, particle size analysis, heavy metal analysis, polymorphism and compatibility studies, extractables and leachables studies, lyophilization studies, reference and working standards, forced degradation studies, and chromatographic method development and validation services.

Indoco Remedies also offers a range of engineering services including architectural design, lighting, mechanical and utility engineering, project and construction management, electrical, control system, piping, structural design, data transfer system, and process engineering.

Their customer base includes general practitioners, pediatricians, consultant physicians, dentists, cardiologists, diabetologists, endocrinologists, gynaecologists, and ophthalmologists.
Company nameListing dateIndustry NSE symbol BSE symbol
Indoco Remedies Limited Jan, 2005 Jan, 2005 Pharmaceuticals Pharmaceuticals INDOCO INDOCO

Shareholding pattern

Sep, 2023 Jun, 2023 Mar, 2023 Dec, 2022 Sep, 2022

  • Promoters 
    58.74%
    Public 
    41.26%
    Shares held by Employee Trusts 
    0.00%
  • Promoters 
    58.73%
    Public 
    41.27%
    Shares held by Employee Trusts 
    0.00%
  • Promoters 
    58.69%
    Public 
    41.31%
    Shares held by Employee Trusts 
    0.00%
  • Promoters 
    58.69%
    Public 
    41.31%
    Shares held by Employee Trusts 
    0.00%
  • Promoters 
    58.69%
    Public 
    41.31%
    Shares held by Employee Trusts 
    0.00%

Indoco Remedies Limited FAQ's

What is the range of today's stock performance for Indoco Remedies Limited?

Today's stock performance witnessed a fluctuation from a minimum of 316.10 on the NSE (National Stock Exchange) to a maximum of 343.55. Similarly, on the BSE (Bombay Stock Exchange), the stock's intraday range extended from a low of 310.25 to a high of 343.90.

What are the 52-week low and high values for Indoco Remedies Limited?

The stock's performance over the past 52 weeks reveals a low of 286.60 (occurred on 04-Jun-2024) and a high of 415.00 (achieved on 20-Jan-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 286.50 (on 04-Jun-2024), and the 52-week high is 416.95 (on 01-Jan-2024).

What was the opening and previous closing prices for Indoco Remedies Limited?

The stock's performance over the past 52 weeks reveals a low of 286.60 (occurred on 04-Jun-2024) and a high of 415.00 (achieved on 20-Jan-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 286.50 (on 04-Jun-2024), and the 52-week high is 416.95 (on 01-Jan-2024).

What is the total volume and traded value for Indoco Remedies Limited for the day?

The total volume is 2, and the total traded value is 7.52 (₹ Lakhs).

What are the upper and lower circuit limits for Indoco Remedies Limited?

The upper circuit limit is 382.50, and the lower circuit limit is 255.00.

What is the market cap and PE ratio for Indoco Remedies Limited?

The market cap is ₹31.54 Cr, and the PE ratio (TTM) is 99.94.

What are the financial metrics such as ROE, EPS, dividend yield, book value, and face value for Indoco Remedies Limited?

ROE is 7.47, EPS is 9.25, book value is not available

What are the revenue and profit figures for the latest quarter and previous quarters for Indoco Remedies Limited?

In Jun 2023, Revenue is ₹243949000.00, and Profit is ₹-23617000.00. In Jun 2023, Revenue is ₹1523300000.00, and Profit is ₹51800000.00.

When was Indoco Remedies Limited listed, and what industry does it belong to?

The company, Indoco Remedies Limited, was listed in Jan 2005 and belongs to the Pharmaceuticals industry. Its NSE symbol is INDOCO.

What is the current shareholding pattern of the Indoco Remedies Limited?

As of latest available update, promoters hold 58.74%, the public holds 41.26%, and Employee Trusts holds 0.00.

The Indian Community

Public Community

Discover the vibrant tapestry of 'The Indian Community' - a melting pot of diverse cultures, traditions, and values. Explore its rich heritage, festivals, and contributions, as this online hub celebrates the essence of India's people, connecting, inspiring, and fostering unity worldwide.

Members
29
online
243
Threads
96
Settings
Back
Top